Anna Lucia Piscitelli
Overview
Explore the profile of Anna Lucia Piscitelli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
43
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Arasi S, Piscitelli A, Cafarotti A, Marziani B, Pecora V, Dahdah L, et al.
World Allergy Organ J
. 2023 Feb;
16(2):100750.
PMID: 36852410
Background: Children with severe food allergy may present high risk of fatal anaphylaxis and a highly impaired quality of life. Anti IgE-treatment has been shown to be a promising approach...
2.
Fierro V, Piscitelli A, Battaglia E, Fiocchi A
Front Pediatr
. 2022 Jul;
10:772704.
PMID: 35813377
The panoply of anti-asthma drugs for children between 6 and 18 years is not limited to those reported in the guidelines. In this review, we will re-assess the role of...
3.
Valluzzi R, Riccardi C, Arasi S, Piscitelli A, Calandrelli V, Dahdah L, et al.
Allergy
. 2022 Jun;
77(10):3052-3060.
PMID: 35652800
Background: The use of eliciting doses (EDs) for food allergens is necessary to inform individual dietary advice and food allergen risk-management. The Eliciting Dose 01 (ED01) for milk and egg,...
4.
De Matteis A, Bracaglia C, Pires Marafon D, Piscitelli A, Alessio M, Naddei R, et al.
Rheumatology (Oxford)
. 2021 Aug;
61(4):1621-1629.
PMID: 34343275
Objective: The objective of this study was to use real-world data to evaluate the effectiveness and safety of canakinumab in Italian patients with systemic JIA (sJIA). Methods: A retrospective multicentre...
5.
Clemente V, Tripiciano C, Moras P, Deriu D, Di Giuseppe M, Piscitelli A, et al.
Ital J Pediatr
. 2021 Jun;
47(1):119.
PMID: 34078420
Background: SARS-CoV-2 infection in children is often non severe and in the majority of cases does not require long term hospitalization, nevertheless it is burdened with social issues and managing...
6.
Bozzola E, Ciarlitto C, Guolo S, Brusco C, Cerone G, Antilici L, et al.
Front Pediatr
. 2021 Feb;
8:594898.
PMID: 33537260
Respiratory syncytial virus (RSV) bronchiolitis is among the leading causes of hospitalization in infants. Prophylaxis with palivizumab may reduce RSV infection, but its prescription is restricted to high-risk groups. The...